4.8 Article

High mTOR activity is a hallmark of reactive natural killer cells and amplifies early signaling through activating receptors

Journal

ELIFE
Volume 6, Issue -, Pages -

Publisher

ELIFE SCIENCES PUBLICATIONS LTD
DOI: 10.7554/eLife.26423

Keywords

-

Categories

Funding

  1. Agence Nationale de la Recherche [ANR-16-CE15-0005-01]
  2. H European Research Council [281025 Dironaki]

Ask authors/readers for more resources

NK cell education is the process through which chronic engagement of inhibitory NK cell receptors by self MHC-I molecules preserves cellular responsiveness. The molecular mechanisms responsible for NK cell education remain unclear. Here, we show that mouse NK cell education is associated with a higher basal activity of the mTOR/Akt pathway, commensurate to the number of educating receptors. This higher activity was dependent on the SHP-1 phosphatase and essential for the improved responsiveness of reactive NK cells. Upon stimulation, the mTOR/Akt pathway amplified signaling through activating NK cell receptors by enhancing calcium flux and LFA-1 integrin activation. Pharmacological inhibition of mTOR resulted in a proportional decrease in NK cell reactivity. Reciprocally, acute cytokine stimulation restored reactivity of hyporesponsive NK cells through mTOR activation. These results demonstrate that mTOR acts as a molecular rheostat of NK cell reactivity controlled by educating receptors and uncover how cytokine stimulation overcomes NK cell education.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Letter Oncology

Childhood Kaposi sarcoma related to hypomorphic severe combined immunodeficiency caused by a novel CORO1A mutation

Audrone Muleviciene, Takuya Sekine, Timo Zondag, Yenan T. Bryceson, Bianca Tesi, Jelena Rascon

PEDIATRIC BLOOD & CANCER (2022)

Article Cell Biology

Infection or a third dose of mRNA vaccine elicits neutralizing antibody responses against SARS-CoV-2 in kidney transplant recipients

Xavier Charmetant, Maxime Espi, Ilies Benotmane, Veronique Barateau, Francoise Heibel, Fanny Buron, Gabriela Gautier-Vargas, Marion Delafosse, Peggy Perrin, Alice Koenig, Noelle Cognard, Charlene Levi, Floriane Gallais, Louis Maniere, Paola Rossolillo, Eric Soulier, Florian Pierre, Anne Ovize, Emmanuel Morelon, Thierry Defrance, Samira Fafi-Kremer, Sophie Caillard, Olivier Thaunat

Summary: Transplant recipients treated with immunosuppression have a lower response to COVID-19 vaccines, but previous infection with SARS-CoV-2 provides some protection. A study found that neutralizing anti-RBD IgG antibodies were the primary correlate of protection for transplant recipients. Immunosuppressive drugs may affect the generation of virus-specific B and T follicular helper cells. Administration of a third dose of SARS-CoV-2 mRNA vaccine improved the RBD-specific responses in transplant patients who had not previously responded to two doses of the vaccine.

SCIENCE TRANSLATIONAL MEDICINE (2022)

Review Immunology

Neuroinflammation Associated With Inborn Errors of Immunity

Hannes Lindahl, Yenan T. Bryceson

Summary: The development of high-throughput sequencing has advanced the understanding of genotype-phenotype correlations in congenital diseases. Neuroinflammatory diseases, although rare, are increasingly recognized among inborn errors of immunity and can have a significant impact on patient care. This review focuses on the signs and symptoms of neuroinflammation associated with pathogenic variants in immune genes and proposes a subdivision based on underlying mechanisms.

FRONTIERS IN IMMUNOLOGY (2022)

Article Oncology

Targeting CISH enhances natural cytotoxicity receptor signaling and reduces NK cell exhaustion to improve solid tumor immunity

Pierre-Louis Bernard, Rebecca Delconte, Sonia Pastor, Vladimir Laletin, Cathy Costa Da Silva, Armelle Goubard, Emmanuelle Josselin, Remy Castellano, Adrien Krug, Julien Vernerey, Raynier Devillier, Daniel Olive, Els Verhoeyen, Eric Vivier, Nicholas D. Huntington, Jacques Nunes, Geoffrey Guittard

Summary: This study investigates the impact of targeting an inhibiting protein called CISH in natural killer (NK) cells on their functions and antitumor properties. The results show that CISH deletion enhances NK cell activation and killing abilities, while limiting NK cell exhaustion. Furthermore, CISH deletion optimizes NK cell accumulation in tumors and improves the effectiveness of antitumor responses. Therefore, CISH has been validated as a potential therapeutic target to enhance NK cell immunotherapy.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2022)

Article Immunology

Group 1 ILCs regulate T cell-mediated liver immunopathology by controlling local IL-2 availability

Valeria Fumagalli, Valentina Venzin, Pietro Di Lucia, Federica Moalli, Xenia Ficht, Gioia Ambrosi, Leonardo Giustini, Francesco Andreata, Marta Grillo, Diletta Magini, Micol Rava, Christin Friedrich, Jason D. Fontenot, Philippe Bousso, Sarah A. Gilmore, Shahzada Khan, Manuel Baca, Eric Vivier, Georg Gasteiger, Mirela Kuka, Luca G. Guidotti, Matteo Iannacone

Summary: Group 1 innate lymphoid cells (ILCs) play a role in controlling T cell-mediated liver immunopathology by limiting local IL-2 concentration.

SCIENCE IMMUNOLOGY (2022)

Article Transplantation

Evolution of humoral lesions on follow-up biopsy stratifies the risk for renal graft loss after antibody-mediated rejection treatment

Antonin Bouchet, Brieuc Muller, Jerome Olagne, Thomas Barba, Melanie Joly, Augustin Obrecht, Maud Rabeyrin, Frederique Dijoud, Cecile Picard, Sarah Mezaache, Antoine Sicard, Alice Koenig, Anne Parissiadis, Valerie Dubois, Emmanuel Morelon, Sophie Caillard, Olivier Thaunat

Summary: For renal transplant recipients, a follow-up biopsy conducted 3-6 months after AMR treatment initiation can help predict long-term outcomes. The evolution of humoral lesions is closely associated with graft survival rates.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2022)

Article Biotechnology & Applied Microbiology

Control of acute myeloid leukemia by a trifunctional NKp46-CD16a-NK cell engager targeting CD123

Laurent Gauthier, Angela Virone-Oddos, Jochen Beninga, Benjamin Rossi, Celine Nicolazzi, Celine Amara, Audrey Blanchard-Alvarez, Nicolas Gourdin, Jacqueline Courta, Alexandra Basset, Magali Agnel, Franceline Guillot, Gwendoline Grondin, Helene Bonnevaux, Anne-Laure Bauchet, Ariane Morel, Yannis Morel, Marielle Chiron, Eric Vivier

Summary: Researchers have developed a novel natural killer cell engager (NKCE) that targets leukemia cells and has potent antitumor activity without toxicity, suggesting its potential for clinical development.

NATURE BIOTECHNOLOGY (2023)

Letter Critical Care Medicine

C5a-C5aR1 Axis Blockade in Patients With Severe COVID-19: Contrasting Results of PANAMO and FORCE

Julien Carvelli, Eric Vivier

CRITICAL CARE MEDICINE (2023)

Article Cell Biology

Prior SARS-CoV-2 infection enhances and reshapes spike protein-specific memory induced by vaccination

Veronique Barateau, Loic Peyrot, Carla Saade, Bruno Pozzetto, Karen Brengel-Pesce, Mad-Helenie Elsensohn, Omran Allatif, Nicolas Guibert, Christelle Compagnon, Natacha Mariano, Julie Chaix, Sophia Djebali, Jean-Baptiste Fassier, Bruno Lina, Katia Lefsihane, Maxime Espi, Olivier Thaunat, Jacqueline Marvel, Manuel Rosa-Calatrava, Andres Pizzorno, Delphine Maucort-Boulch, Laetitia Henaff, Mitra Saadatian-Elahi, Philippe Vanhems, Stephane Paul, Thierry Walzer, Sophie Trouillet-Assant, Thierry Defrance

Summary: The history of infection and vaccination modality impact the immune memory of individuals vaccinated against SARS-CoV-2. A long-term follow-up study was conducted on unvaccinated and vaccinated COVID-19 convalescent individuals, as well as infection-naive vaccinated individuals, to understand how these factors affect immune memory. The study found that convalescent vaccinated individuals had the highest concentrations of spike protein-specific antibodies and increased frequencies of a specific memory B cell subset, suggesting enhanced protection at mucosal sites.

SCIENCE TRANSLATIONAL MEDICINE (2023)

Review Immunology

Natural killer cells and type 1 innate lymphoid cells in cancer

Noella Lopes, Eric Vivier, Emilie Narni-Mancinelli

Summary: The article introduces the developmental trajectory and cytokine production profile of innate lymphoid cells (ILCs). It describes the subsets, effector functions, and development of NK cells and ILC1s, and discusses their role in cancer and the effects of the tumor microenvironment on their metabolism.

SEMINARS IN IMMUNOLOGY (2023)

Review Medicine, General & Internal

Rescue of Pap-Mas in Systemic JIA Using Janus Kinase Inhibitors, Case Report and Systematic Review

Franck Zekre, Anita Duncan, Audrey Laurent, Maud Tusseau, Remi Pescarmona, Sophie Collardeau-Frachon, Camille Ohlmann, Sebastien Viel, Philippe Reix, Sarah Benezech, Alexandre Belot

Summary: Biological disease-modifying anti-rheumatic drugs (bDMARDs) targeting IL-6 and IL-1 beta are commonly used as a first-line therapy for systemic-onset juvenile idiopathic arthritis (sJIA), but they may increase the risk of pulmonary alveolar proteinosis (PAP). We report a new case of PAP-MAS successfully treated with Janus Kinase inhibitors (JAKi) and review previous clinical descriptions of this condition. Among the analyzed articles, the incidence of PAP-MAS among sJIA patients ranged from 1.28% to 12.9%. JAKi shows promise in treating lung disease associated with sJIA.

JOURNAL OF CLINICAL MEDICINE (2023)

Article Biology

Myc controls NK cell development, IL-15-driven expansion, and translational machinery

Hanif J. Khameneh, Nicolas Fonta, Alessandro Zenobi, Charlene Niogret, Pedro Ventura, Concetta Guerra, Ivo Kwee, Andrea Rinaldi, Matteo Pecoraro, Roger Geiger, Andrea Cavalli, Francesco Bertoni, Eric Vivier, Andreas Trumpp, Greta Guarda

Summary: This study reveals the importance of MYC in NK cells and its role in regulating translation and expansion, as well as anticancer immunity. Deficiency of MYC in NK cells results in reduced numbers and impaired cytotoxic functions of mature NK cells.

LIFE SCIENCE ALLIANCE (2023)

Editorial Material Rheumatology

Assessment of type I interferon response in routine practice in France in 2022

Anais Nombel, Anne Perrine Foray, Lorna Garnier, Christine Lombard, Eric Hachulla, Brigitte Bader-Meunier, Sophie Georgin-Lavialle, Isabelle Melki, Thierry Walzer, Alexandre Belot, Sebastien Viel

Summary: An European Alliance of Associations for Rheumatology task force has suggested specific considerations for studying the type I interferon pathway, noting the lack of validated assays for clinical use. In this report, we present the French experience of using a type I interferon pathway assay routinely since 2018 in Lyon, France.

RMD OPEN (2023)

Article Biotechnology & Applied Microbiology

High-efficiency transgene integration by homology-directed repair in human primary cells using DNA-PKcs inhibition

Sridhar Selvaraj, William N. Feist, Sebastien Viel, Sriram Vaidyanathan, Amanda M. Dudek, Marc Gastou, Sarah J. Rockwood, Freja K. Ekman, Aluya R. Oseghale, Liwen Xu, Mara Pavel-Dinu, Sofia E. Luna, M. Kyle Cromer, Ruhi Sayana, Natalia Gomez-Ospina, Matthew H. Porteus

Summary: A small molecule inhibitor called AZD7648 was found to significantly increase the efficiency of homology-directed repair (HDR) and decrease genomic insertions/deletions (INDELs) in human primary cells. This approach has the potential to improve therapeutic efficacy of cell-based therapies and expand the use of targeted integration as a research tool.

NATURE BIOTECHNOLOGY (2023)

Review Immunology

Germinal center-dependent and -independent immune responses of tumor-infiltrating B cells in human cancers

Eve Playoust, Romain Remark, Eric Vivier, Pierre Milpied

Summary: B cells are crucial for immunity and are involved in affinity maturation and differentiation through B-cell receptor signals and signals from the microenvironment. They have been discovered to play important roles in antitumor responses in human cancers, but their dynamics and interplay are not well understood. B-cell responses involve both GC-dependent and GC-independent pathways, with affinity maturation occurring in GC reactions. Reactivation of high-affinity Bmem cells leads to the production of large numbers of PCs without BCR rediversification. Multiple tools and techniques are needed to understand B-cell dynamics in immune responses. Studying TIL-B cells and TIL-PC in solid tumors can provide insights for antitumor therapies.

CELLULAR & MOLECULAR IMMUNOLOGY (2023)

No Data Available